Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
International Journal of Breast Cancer
|
February 2, 2012
Oncoplastic approaches to breast conservation
Dennis R Holmes, Wesley Schooler, Robina Smith
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|
January 9, 2004
Emergent laparoscopic reduction of acute gastric volvulus with anterior gastropexy
H Joseph Naim, Robina Smith, Piotr J Gorecki
Annals of Vascular Surgery
|
March 28, 2008
Acute arterial occlusion after ultrasound-guided thrombin injection of a common femoral artery pseudoaneurysm with a wide, short neck
Marcus D'Ayala, Robina Smith, Gregory Zanieski, et al.
Future Oncology (London, England)
|
July 23, 2024
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed, Josep Tabernero, Aparna Parikh, et al.
Lancet (London, England)
|
October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
J Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
International Journal of Breast Cancer
|
February 2, 2012
Oncoplastic approaches to breast conservation
Dennis R Holmes, Wesley Schooler, Robina Smith
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|
January 9, 2004
Emergent laparoscopic reduction of acute gastric volvulus with anterior gastropexy
H Joseph Naim, Robina Smith, Piotr J Gorecki
Annals of Vascular Surgery
|
March 28, 2008
Acute arterial occlusion after ultrasound-guided thrombin injection of a common femoral artery pseudoaneurysm with a wide, short neck
Marcus D'Ayala, Robina Smith, Gregory Zanieski, et al.
Future Oncology (London, England)
|
July 23, 2024
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed, Josep Tabernero, Aparna Parikh, et al.
Lancet (London, England)
|
October 23, 2025
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
J Randolph Hecht, Young Suk Park, Josep Tabernero, et al.
Page
of 1